Transcripts NFL Biosciences

Stocks

Real-time Euronext Paris Other stock markets 18:04:14 29/07/2026 HKT			5-day change	1st Jan Change
0.8290 ^EUR	+1.10%		-0.12%	-29.63%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-08	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI